Search
Disclaimer
Clicking the images or links will redirect you to a website hosted by BenchSci that provides third-party scientific content. Neither the content nor the BenchSci technology and processes for selection have been evaluated by us; we are providing them as-is and without warranty of any kind, including for use or application of the Thermo Fisher Scientific products presented.
Rockland
Avian Influenza A H7N9 Neuraminidase Polyclonal Antibody
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Avian Influenza A H7N9 Neuraminidase Antibody (600-401-Z04) in ELISA
ELISA results of purified Rabbit anti-H7N9 Neuraminidase antibody tested at 1 µg/mL detects 10 ng of H7N9 Influenza A virus [A/blue-winged teal/Ohio/566/2006(H7N9)] Neuraminidase peptide, and not 10 ng of H7N9 Influenza A virus [A/Shanghai/02/2013(H7N9)] Neuraminidase peptide.
产品信息
600-401-Z04
产品规格
种属反应
Virus
宿主/亚型
Rabbit
/ IgG
分类
Polyclonal
类型
Antibody
抗原
Anti-Avian Influenza A H7N9 Neuraminidase antibody was prepared from whole rabbit serum produced by repeated immunizations with a synthetic peptide corresponding to 11 amino acids near the N-terminus of the H7N9 Neuraminidase protein.
偶联物
形式
Liquid
浓度
1 mg/mL
纯化类型
Affinity chromatography
保存液
PBS, pH 7.2
内含物
0.02% sodium azide
保存条件
-20°C, Avoid Freeze/Thaw Cycles
运输条件
Ambient (domestic); Wet ice (international)
靶标信息
Influenza A H7N9 is a subtype of the influenza virus distinguished by its hemagglutinin H7 and neuraminidase N9 proteins. The neuraminidase (NA) component is a critical enzyme enabling viral release from infected cells, facilitating the spread of virions within the host. The structure of NA in H7N9 is pivotal for understanding its role in viral pathogenicity and drug resistance. Mutations in NA, such as NA-I222T and NA-H274Y, contribute to antiviral resistance, especially against neuraminidase inhibitors like oseltamivir, which are commonly used therapeutics. These mutations affect the catalytic efficiency and binding affinity of NA for its inhibitors, posing challenges to clinical management and emphasizing the necessity for ongoing surveillance and molecular characterization. The immunogenicity of vaccines targeting both HA and NA proteins is being explored to enhance protective responses against diverse influenza strains. Understanding the evolution and function of H7N9 NA informs the development of effective vaccines and contributes to the strategic planning for influenza outbreak prevention and control.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
篇参考文献 (0)
您是否在文献中引用过该产品？请点击下方按钮邮件告知我们。
